Tavexia Lifecare Board Approves Un-audited Results, Fund Raising Proposal

Tavexia Lifecare Ltd announced that its Board of Directors, in a meeting held on November 4, 2026, approved the Un-Audited Financial Results (Standalone and consolidated) for the Quarter and half-year ended September 30, 2026. The Board also approved the Limited Review Report from M/s DEVAM & Associates LLP. Additionally, the company approved a proposal for raising funds up to ₹68 Crore for the proposed acquisition of 60% equity in Meyonex Pharmaceuticals Limited. The Board also approved the change of Registrar & Transfer Agent from Niche Technologies Pvt. Ltd to Skyline Financial Services Pvt. Ltd.